Pfizer bought G...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Global Blood Therapeutics
Pfizer bought Global Blood Therapeutics
10/5/22 at 16:56
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.
Global Blood Therapeutics
Review
Source:
investors.pfizer.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Aeroflot reported for 3 months of 2024 by RAS
4/27/24
AFLT
Board of Directors of Magnitogorsk Iron and Steel Works recommended that dividends be paid for 2023
4/27/24
MAGN
Volgogradenergosbyt reported for 3 months of 2024 by RAS
4/27/24
VGSB
Board of Directors of Europlan recommended that dividends be paid for 2023
4/27/24
LEAS
Board of Directors of UK Arsagera recommended that dividends be paid for 2023
4/27/24
ARSA
Yakovlev reported for 2023 by IFRS
4/27/24
IRKT
TNS Energo Nizhny Novgorod reported for 3 months of 2024 under RAS
4/27/24
NNSB
Polyus reported for 3 months of 2024 by RAS
4/27/24
PLZL
LSR reported for 3 months of 2024 by RAS
4/27/24
LSRG
KuibyshevAzot reported for 3 months of 2024 by RAS
4/27/24
KAZT
«
Previous
5
6
7
8
9
10
11
12
13
14
»
Next
BlackTerminal.com 2016 - 2024.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)